Answers are grounded in this paper and cite their sources.
In an editorial entitled “Is it time to standardize granulocyte alloantigen nomenclature?”1 in the April 2002 issue of TRANSFUSION, the authors recommend adaptation of a new nomenclature that has been constructed by the Granulocyte Antigen Working Party.2 Two reasons are given for the proposed changes. First, it is stated that the currently used multiple nomenclatures make progress in the field difficult to follow, especially for nonexperts in the field. Second, it is pointed out that the existing nomenclature does not address the encoding genes, which were unknown at the time that the antigens were first identified. Unfortunately, for the reasons described below, the proposed new nomenclature fails to serve the intended purposes, has opposite effects, and should not be accepted for general use. The familiar “N” terminology (NA1, NA2, NB1, NB2) was designed to define antigens exclusively expressed on blood neutrophils, and to distinguish them from the antigens that are present on neutrophils as well as other cell types. In the N nomenclature, alphabetical letters indicate the presumed loci (NA, NB, etc.) followed by numbers, which define the alleles. The proposed new nomenclature violates the simple principle of recognizing neutrophil specificity and lumps together heterogeneous groups of antigens with diverse tissue distributions and biological implications. For example, the antigen 5b, proposed to be renamed HNA-3a (human neutrophil antigen-3a) is an antigen expressed on all solid tissues as well as hematopoietic cells. In contrast, the Ond and Mart antigens located on CD11a and CD11b, respectively, which are proposed to be renamed HNA-4 and HNA-5, are adhesion molecules expressed on both neutrophils and other hematopoietic cells. If the logic for the proposed nomenclature is followed, one may question why HNA designation should be limited to CD11a and CD11b and not include CD11c, CD35, I and i and numerous other antigens that are also found on neutrophils, with known and unknown polymorphisms. It seems more reasonable to keep the non-neutrophil specific antigens under their existing and familiar designations and avoid creating an indigestible, illogic and unnecessary new nomenclature. Clinically, neutrophil specificity as a limited target for the maternal antibodies is essential for the development of alloimmune neonatal neutropenia. In contrast, fetal-maternal incompatibility involving non-neutrophil specific antigens, proposed to be renamed as HNA-3, HNA-4 or HNA-5, do not cause alloimmune neutropenia. Neither have the latter group of antigens, in contrast to neutrophil-specific antigens, been implicated in autoimmune neutropenia. Thus, the proposed nomenclature leaves the readership confused and makes it impossible to readily discern the distinct clinical significance of these antigens. The addition of the letter H to NA in the proposed nomenclature to describe HNA, human neutrophil antigens, is inappropriate because these antigens are also found on the neutrophils from some nonhuman primates. NB1 is found on the neutrophils of baboons and chimpanzees, and NA2 is expressed on the neutrophils of chimpanzees. The reasoning for the addition of the letter H to NA, which is intended to make neutrophil antigen nomenclature consistent with that of the HLA system, is flawed. As one of the original investigators who coined the term HL-A, I can state that the letter H in HL-A, later changed to HLA, was not intended to define a human connection. To resolve the possible confusion that may have been created by this and previous communications, an updated nomenclature for neutrophil-specific antigens is proposed in Table 1, in which the familiar N designation is retained but the antigens that neutrophils share with other cells are excluded. This updating, which also allows for future discoveries, includes the addition of genetic information as proposed by the Granulocyte Antigen Working Party. In this updated nomenclature, in contrast to the Granulocyte Antigen Working Party proposal, a numerical harmony exists between the antigens and their corresponding encoding allele designations shown in Table 1. As proposed by Stroncek and Bux, single base substitutions within major neutrophil-specific antigens could be called variants in which substitutions are specifically described in the allelomorphs. For example, single nucleotide variation within the gene encoding NA1 antigen could be described as FCGR3B*1G277A.
No takes yet. Share an insight, caveat, or question.
Parviz Lalezari (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: